Announcements
The American Journal of Tropical Medicine and Hygiene Publishes Consensus Points from Global Experts on the Potential Risks of Using Gene Drive Mosquitoes to Control Malaria
December 9, 2016 – The American Journal of Tropical Medicine and Hygiene published a systematic evaluation of potential risks associated with the use of mosquitoes genetically modified through gene drive technology to reduce the burden of malaria in Africa.
Framework for Biomarker Evidentiary Criteria Released
December 6, 2016 — The Foundation for the National Institutes of Health (FNIH) announced today the release of the “Framework for Defining Evidentiary Criteria for Biomarker Qualification.” Developed in partnership with government and industry stakeholders, the framework defines the level of evidence needed to support qualification of biological markers (biomarkers). The document is a result of a broad-based effort by the FNIH, the U.S.
Foundation for the National Institutes of Health Receives Grant from Amie’s Place Foundation to Expand Research on the Benefits of Human-Animal Interaction
November 2, 2016 —The Foundation for the National Institutes of Health (FNIH) has received a $165,000 grant award from Amie’s Place Foundation, a New York-based not-for-profit dedicated to keeping families and pets together, to help advance research on the therapeutic benefits of human-
Training the Next Generation of Clinician Scientists through the NIH Medical Research Scholars Program (MRSP) Q&A with esteemed MRSP Alum Kyle Vining, DDS, Harvard University
October 25, 2016 — This fall, 52 medical and dental students began intensive research training at the National Institutes of Health (NIH) through the Medical Research Scholars Program (MRSP). This one-year program offers students opportunities to engage in research early in their careers, while addressing the critical need for a pipeline of talented scientists capable of turning discovery into improved health.
Salk Institute Presents FNIH Board Member Solomon H. Snyder, M.D., with Medal for Research Excellence
October 5, 2016 — Renowned neuroscientist Solomon H. Snyder, M.D., FNIH Board Vice Chairman for Science, was awarded the Salk Institute’s Medal for Research Excellence. This award, which has only been bestowed twice since the Salk Institute was established 56 years ago, honors individuals making significant contributions to basic science research with particular advances to policy, humanities, human health or the Institute.
The FNIH Earns 100% Score from Charity Navigator
June 14, 2016 — Charity Navigator, America’s largest independent charity evaluator, has again awarded the Foundation for the National Institutes of Health (FNIH) its highest, 4-star rating—this time with a perfect (100%) score.
The FNIH’s Statement on the Democratic Staff Report of the Committee on Energy and Commerce
May 23, 2016 — This morning, the Democratic Staff of the Committee on Energy and Commerce issued a report on the Sports and Health Research Program (SHRP), a partnership among the National Institutes of Health (NIH), National Football League (NFL) and the Foundation for the National Institutes of Health (FNIH). The following is the FNIH’s response to the report.
The FNIH Launches New Project to Evaluate the Effectiveness of Liquid Biopsies as Biomarkers in Colorectal Cancer Patients
May 3, 2016 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium is launching a research partnership to determine whether liquid biopsies can be used instead of traditional solid tumor biopsies for diagnosing and monitoring metastatic colorectal cancer.
The FNIH Launches New Program Focused on Assessment of Cardiovascular Risk Biomarkers in U.S. Population
March 24, 2016 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a 4-year project to transform our ability to characterize risk for developing cardiovascular disease. The project is poised to improve identification and care of at-risk patients through a comprehensive investigation that will measure novel biomarkers in a national study consisting of more than 25,000 samples.